Opening in Bureauify…
ClosedRegulation

Ajinomoto Co., Inc.; Filing of Food Additive Petition; Amendment

Health and Human Services Department, Food and Drug Administration

Closed
NAICS 325412
Source: Federal Register
OverviewIntelligenceProposals

Key Details

Posted Date
Response Deadline
NAICS Code
325412
Source
Federal Register
Contract Type
regulation

Description

The Food and Drug Administration (FDA) is amending the filing notice for a food additive petition filed by Ajinomoto Co., Inc., to indicate that the petitioned additive, N-[N-[3-(3-hydroxy-4- methoxyphenyl) propyl-[alpha]-aspartyl]-L-phenylalanine 1-methyl ester, monohydrate (proposed additive name Advantame, CAS Reg. No. 714229-20- 6), is for use as a non-nutritive sweetener and flavor enhancer in foods generally, except meat and poultry. The previous filing notice indicated that the proposed additive was for use as a non-nutritive sweetener in tabletop applications and powdered beverage mixes.

Key Dates

Posted:Deadline:

Frequently Asked Questions

Is this regulation still open?+
No — the response deadline for this regulation has passed (November 26, 2012). Browse other active Health and Human Services Department, Food and Drug Administration opportunities on Bureauify.
How do I apply for this regulation?+
Review the full solicitation documents on the source website (SAM.gov or Grants.gov), prepare your proposal per the instructions, and submit before the deadline. Use Bureauify to track the opportunity and get reminders.

Track This Regulation

Get alerts and track updates with Bureauify.

Track in BureauifyView on Federal Register

Intelligence

  • Win probability analysis
  • Competitive landscape
  • Incumbent analysis
  • Price-to-win estimate
  • Similar awards history
Open in Bureauify for full intelligence →

Data sourced from Federal Register

Search Government Records

100M+ government records — search across all categories

Ajinomoto Co., Inc.; Filing of Food Additive Petition; Amend — Health and Human Services Department, Food and Drug Administration | Bureauify